Abstract-Osteopontin (OPN) is a cytokine upregulated in diabetic vascular disease. To better understand its role in vascular remodeling, we assessed how OPN controls metalloproteinase (MMP) activation in aortic adventitial myofibroblasts (AMFs) and A7r5 vascular smooth muscle cells (VSMCs). By zymography, OPN and tumor necrosis factor (TNF)-␣ preferentially upregulate pro-matrix metalloproteinase 9 (pro-MMP9) activity. TNF-␣ upregulated pro-MMP9 in AMFs isolated from wild-type (OPN ϩ/ϩ ) mice, but pro-MMP9 induction was abrogated in AMFs from OPN Ϫ/Ϫ mice. OPN treatment of VSMCs enhanced pro-MMP9 activity, and TNF-␣ induction of pro-MMP9 was inhibited by anti-OPN antibody and apocynin. Superoxide and the oxylipid product 8-isoprostaglandin F 2 ␣-isoprostane 
n epidemic of diabetes is assailing the world as Westernized lifestyles become prevalent. 1 Diabetic macroand microvascular diseases result in blindness, renal insufficiency, and cardiovascular mortality. 1 For 2 decades, it has been appreciated that diabetes elicits genomic responses in the intima, media, and adventitia of muscular arteries 2 ; hyperglycemia-induced changes in gene expression, mural oxidative stress, and matrix remodeling occur in all 3 vascular compartments. 3 Because macrovascular disease progresses for several years before clinically overt diabetes, 1 a better understanding of the mechanisms whereby glucose exerts changes in vascular structure and function is required.
The signals mediating low-grade medial and adventitial inflammation of diabetes are only beginning to be understood. Diabetes-induced vascular tumor necrosis factor (TNF)-␣ expression and NADPH oxidase activate mural cell-mediated immunity as 1 early component. 3 In addition to osmotic stress, both proximal (glucosamine, myoinositol) and distal (advanced glycosylation end products) glucose metabolites participate in vascular disease. 3 We have identified that the cytokine osteopontin (OPN) is also upregulated in the aortic wall during diabetes. 4, 5 Intracellular glucose metabolism and transcriptional activation via upstream stimulatory factor 1 (USF1) and activator protein 1 (AP1) mediate OPN induction. 5 OPN enhances adventitial myofibroblast (AMF) and vascular smooth muscle cell (VSMC) migration and proliferation, 6 promotes vascular matrix metalloproteinase 9 (MMP9) activation, 6, 7 augments cell-mediated immunity, 8 and inhibits matrix calcium accumulation. [7] [8] [9] OPN is required for angiotensin II (AT-II)-induced aortic aneurysm forma-tion. 7 Because OPN transgenic mice exhibit increased arterial medial thickness and mural cell proliferation, 6 hyperglycemia-induced vascular OPN expression may contribute to the intimal-medial thickening, enhanced remodeling, and reduced macrovascular compliance of dysglycemic patients. 1 MMP9 is a key downstream mediator, because it promotes angiogenesis and vascular remodeling. 10 To better understand the role of OPN in diabetic vascular disease, we assessed effects of OPN signaling on primary aortic AMF and aortic A7r5 VSMC physiology. We identify that OPN, via the N-terminal SVVYGLR motif (SLAYGLR in rodents), preferentially upregulates vascular pro-MMP9 activity by augmenting superoxide generation and oxylipid formation.
Materials and Methods

Reagents
Biochemicals were from Fisher or Sigma. Antibody to NADPH oxidase 2 (Nox2) was from Transduction Laboratories. Antibodies to other NADPH oxidase subunits, eIF2-␣, and normal goat or rabbit immunoglobulin were from Santa Cruz Biotechnology. Antibody against MMP9 was from Chemicon. Precast 10% Zymogram Gelatin Gel and 12% Zymogram Casein Gel zymography kits were purchased from Invitrogen. The human MMP9 Biotrak Activity Kit (Amersham technical bulletin RPN2614PL Rev-B, 2004) was purchased from GE Healthcare. Bovine OPN (bOPN), OPN neutralizing antibody, and TNF-␣ were from R&D Systems. The 8-IsoP ELISA kit (no. 516351) and 8-IsoP (no. 16350) were purchased from Cayman. Dihydroethidium (DHE) was from Molecular Probes. The GRGDS and GRGES peptides were from Bachem. Custom synthetic heptapeptides SVVYGLR and SLAYGLR were from Invitrogen.
Quantitative Gelatin Zymography and Superoxide Detection in Cultured Cells
Before each analysis, 0.5 million aortic VSMCs were plated on a 15-cm tissue culture dish, grown until confluent, and then seeded at high cell densities, ie, 0.5 to 0.75ϫ10 5 cells per well (96-well plates) or 1.0 to 1.5ϫ10 5 cells per well (12-well plates). Treatment with 30.5 mmol/L glucose versus the 5.5 mmol/L glucoseϩ25 mmol/L mannitol osmotic control was performed in basal medium, Eagle's (BME). All other treatments were performed in serum-free DMEM (25 mmol/L glucose) for 18 hours. Twenty-microliter aliquots of serum-free conditioned media were analyzed by zymography (2 to 4 replicates) using precast 10% Zymogram Gelatin Gels (Invitrogen/ Novex) per the instructions of the manufacturer (Novex technical bulletin IM-1002, Version B). With constant gentle agitation, gels were renatured for 30 minutes at room temperature, developed overnight at 37°C, fixed and stained with Colloidal Blue (Novex technical bulletin IM-6025), and extensively washed (Ͼ20 hours) to yield uniform background signal, and digital images of stained wet gels were captured using a Hewlett-Packard ScanJet 5370C bed scanner. Image analysis for was performed by importing scanned JPEG images into Kodak 1D image analysis software essentially as previously described 11 but using net pixel intensity of the pro-MMP9 zymogram with uniform rectangular region of interest to quantify MMP activity. For 8-IsoP determination, 25-to 50-L aliquots were used in immunoassays (nϭ4 per group). For superoxide detection, cells were plated as above, rinsed with DMEM, incubated with 5 mol/L DHE in DMEM for 20 minutes, and rinsed, and light and fluorescence microscopy with digital image was capture performed as described. 12, 13 Image analysis for net pixel intensity was performed by importing JPEG images into Kodak 1D image analysis software using uniform region of interest area for pro-MMP9 f-bands. 14 To better understand the role of OPN in diabetic vascular disease, we examined the effects on MMP9 in primary aortic AMFs and A7r5 VSMCs. Previous data suggested that pro-MMP9 might be the preferentially activated by an OPN transgene. 6 Therefore, we focused on enzyme activity via gelatin zymography, a robust MMP9 and pro-MMP9 assay. 7 Like AT-II, OPN and TNF-␣ increased cellular gelatinase activity; however, whereas AT-II activated both MMP9 and pro-MMP9, OPN and TNF-␣ preferentially upregulated pro-MMP9 ( Figure 1A ). Image analysis of zymograms from multiple independent experiments (supplemental Figure IA 
Inhibitors of Superoxide Signaling Reduce Pro-MMP9 Activation by TNF-␣ and OPN
Many inflammatory cytokines signal via nuclear factor (NF)-B, a well-characterized transcription factor that supports expression of MMP9. 15 Thus, we considered that NF-B might mediate pro-MMP9 activation in aortic AMFs and VSMCs. The thiol reagent N-acetylcysteine (NAC) 16 and IKK inhibitor BAY 11-7082 (BAY) 17 both inhibit NF-B signaling but via distinct mechanisms (supplemental Figure  IIA) . Therefore, we examined the effects of these compounds on pro-MMP9 activation in A7r5 cells. As shown in Figure  2A , both compounds are active as inhibitors of TNF-␣-induced NF-B signaling, indicated by the transfected reporter NF-B-LUC. Surprisingly, whereas NAC inhibited pro-MMP9 activation at high cell densities, BAY did not ( Figure 2B and supplemental Figure IIB and IIC). NAC also suppresses superoxide generation 18 ; therefore, we assessed the effects of diphenyleneiodonium (DPI) and apocynin on pro-MMP9 activation. Apocynin (inhibits p47 and p67 cytosol-to-membrane translocation) and DPI (targets heme b in NADPH oxidase subunits as well as flavin centers) are mechanistically distinct inhibitors of cellular superoxide generation routinely used to functionally test contributions of NADPH oxidases to signal transduction. 12, 18 Like NAC, DPI reduced TNF-␣ induction of pro-MMP9 by Ϸ50% (supplemental Figure IIB ). Similar results were obtained with apocynin, which preferentially abolished TNF-␣ induction of pro-MMP9 ( Figure 2C and 2D). The enzyme superoxide dismutase (SOD) catalytically destroys superoxide to generate oxygen and hydrogen peroxide. 18 As observed with NAC, apocynin, and DPI, treatment with SOD prevented pro-MMP9 activation by either TNF-␣ or OPN (not shown). Thus, redox signaling participates in cytokine activation of pro-MMP9.
Superoxide and Superoxide-Generating NADPH Oxidase Subunits Are Regulated by OPN
Inhibition of pro-MMP9 activation by NAC, DPI, apocynin, and SOD strongly suggested that superoxide production was a component of OPN signaling. Therefore, we examined the effects of OPN on superoxide generation as revealed by fluorescence staining with DHE, a compound chemically oxidized to the fluorescent DNA intercalating agent ethidium in proportion to the amount of superoxide present. 12, 14 As compared with OPN ϩ/ϩ aortic AMFs, OPN Ϫ/Ϫ aortic AMFs exhibited reduced DHE staining ( Figure 3A ). Because NADPH oxidases are embedded in the membrane bilayer, the short-lived superoxide radicals react with membrane lipids, generating oxylipids 19 that demarcate and mediate oxidative signaling. 18 One category of oxylipids, isoprostanes, arises from the chemical oxidation of arachidonic acid in phospholipids. 20 Therefore, we assessed the relationship between OPN, isoprostane production (8-IsoP), and pro-MMP9 activation in AMFs. 8-IsoP is reduced by 50% in OPN Ϫ/Ϫ AMFs as compared with OPN ϩ/ϩ controls ( Figure 3B ). Moreover, exogenous OPN protein upregulated DHE staining ( Figure  3C ) and 8-IsoP ( Figure 3D ) in A7r5 VSMCs. Furthermore, anti-OPN neutralizing antibody inhibited basal 8-IsoP production by 50%, presumably via inhibition of endogenous OPN, 5 whereas an isotype-matched control antibody had no effect ( Figure 3D ).
NADPH oxidases are specific but heterogeneous complexes of p67, p47, p40, and p22 subunits with cell typespecific NADPH oxidase subunits. 18 Other important interacting proteins (eg, the Rac family GTPases and cortactin) convey regulatory responses to vasculotropic hormones such as AT-II. 21 In human and rodent aortic medial VSMCs, Nox1 is a predominant isoform, 18, 22 whereas Nox2 is highly expressed in aortic AMFs. 23 Therefore, we assessed the levels of NADPH oxidase subunit in aortic AMFs from OPN ϩ/ϩ versus OPN Ϫ/Ϫ mice. As shown in Figure 3E , Nox2, Nox1, p67, and p47 are reduced in cell extracts from OPN Ϫ/Ϫ AMFs as compared with OPN ϩ/ϩ controls. No reduction of the housekeeping protein eIF-2␣ was observed in OPN Ϫ/Ϫ AMFs ( Figure 3E ). Because Pagano and colleagues had demonstrated a critical role for Nox2 in AMF physiology, 23 we emphasized Nox2 and its associated subunits. Western blots analyzed from 3 independent sets of cultures demonstrated a Ͼ50% reduction in Nox2 accumulation in OPN Ϫ/Ϫ AMFs versus OPN-replete control cultures ( Figure 3F ). Of note, p67-a regulatory subunit required for electron transport between NADPH and the flavin center that generates superoxide 18 -is reduced along with Nox2 in OPN Ϫ/Ϫ AMFs ( Figure 3E) . Moreover, addition of exogenous OPN upregulated p67 in A7r5 VSMCs (supplemental Figure IIIA) . Finally, a validated antisense oligonucleotide (ASO) directed to p47 significantly reduced 8-IsoP levels in A7r5 cells (supplemental Figure IIIB) , confirming contributions of prototypic NADPH oxidases to A7r5 oxylipid formation. Thus, superoxide production, oxylipid formation, and NADPH oxidase subunit accumulation is regulated by OPN in aortic mesenchymal cells.
The OPN Peptide SVVYGLR Activates Vascular Pro-MMP9 and Superoxide Signaling In Vitro
OPN is a phosphorylated glycoprotein, processed by thrombin to generated N-terminal and C-terminal domains with unique bioactivities 8 (supplement Figure IVA) . Like fulllength bOPN ( Figure 1A and 1B above, and data not shown), the N-terminal recombinant murine OPN fragment dosedependently activates pro-MMP9 (Figure 4A) , whereas the C-terminal OPN fragment is inactive (not shown). The N-terminal domain of OPN contains ␣v␤3 and ␣4␤1 or ␣4␤7 binding subdomains that mediate adhesion and signaling. 8 Of note, a synthetic peptide corresponding to the SVVYGLR motif of human OPN upregulated pro-MMP9 activity ( Figure  4B ); GRGDS and GRGES peptides were insufficient. Similar results were observed with murine OPN SLAYGLR peptide (not shown). We confirmed these results using HA-VSMCs, and an independent immunoassay specific for human pro-MMP9; 50 mol/L SVVYGLR upregulated pro-MMP9 approximately 6-fold ( Figure 4C , Pϭ0.029, 2-tailed t test). Induction of pro-MMP9 by TNF-␣ is poor in AMFs from OPN Ϫ/Ϫ mice ( Figure 4D ; also Figure 1C ). However, incuba- tion with either 50 mol/L SVVYGLR peptide (lanes 3 and 4) or 50 nmol/L bOPN (lanes 5 to 6) restored robust TNF-␣ induction of pro-MMP9 ( Figure 4D ). Thus, OPN signaling via the SVVYGLR motif plays an important role in pro-MMP9 activation. We next evaluated effects of OPN peptides on superoxide and oxylipid formation. Like full-length OPN, recombinant OPN N-terminal fragment increased A7r5 8-IsoP production; OPN C-terminal domain did not ( Figure 5A ). Moreover, the N-terminal heptapeptide SVVYGLR, but not GRGDS or GRGES, upregulated 8-IsoP ( Figure 5B ). SVVYGLR upregulated superoxide (DHE staining) in A7r5 VSMCs (2-fold; supplemental Figure VA) and OPN Ϫ/Ϫ AMFs (5-fold; not shown), quantified by digital image analysis. Thus, the OPN N-terminal domain encodes motifs necessary for pro-MMP9 activation and superoxide and oxylipid formation.
The OPN Peptide SVVYGLR Activates Vascular Pro-MMP9 and Superoxide Signaling In Vivo
We next injected SVVYGLR (nϭ5) or vehicle (nϭ5) into OPN ϩ/Ϫ mice, an in vivo background partially deficient in endogenous OPN tone. Intraperitoneal SVVYGLR administration (8 g/g) significantly upregulated pro-MMP9 activity in aortic extracts (Pϭ0.03; Figure 6A ). Mural actions of SVVYGLR were spatially resolved by DHE staining of aortic frozen sections; adventitial and medial tunics exhibited enhanced superoxide production ( Figure 6B and 6C) , indicating cellular responses in both compartments. Pretreatment of sections with PEG-SOD reduced nuclear DHE staining, but not elastin autofluorescence, confirming superoxidegenerated signal ( Figure 6B, e and f) . SVVYGLR significantly upregulated aortic 8-IsoP in vivo ( Figure 6D ; Pϭ0.019). Moreover, Western blot analysis of individual aortic extracts confirmed that, as observed with in vitro (supplemental Figure IIIA) , aortic Nox2 protein levels were upregulated 2.3-fold by OPN SVVYGLR peptide in vivo (Pϭ0.07 for trend approaching significance, supplemental Figure VB, nϭ5 per group) . To examine the generality of signaling, we assessed pro-MMP9 activation by SVVYGLR in pulmonary tissues. As observed in aorta, SVVYGLR upregulates pro-MMP9 activity in lung ( Figure 6E and 6F) .
Thus, OPN peptide SVVYGLR upregulates levels of vascular superoxide, aortic 8-IsoP formation, and tissue pro-MMP9 activation in vivo.
8-IsoP and Aortic Pro-MMP9 Are Reduced in OPN-Deficient LDLR ؊/؊ Mice Fed High-Fat Diabetogenic Diets
We wished to examine whether OPN signaling was important for vascular stress responses to diabetes in vivo. The male LDLR Ϫ/Ϫ mouse has proven useful for studies of diet-induced diabetes, dyslipidemia, and vascular disease. 4 ,11 Therefore, we studied the effect of high-fat diabetogenic diets (Western Figure 7A ). Seven weeks of a high-fat diet generated equivalent diabetes (meanϮSEM: glucose of 514Ϯ31 versus 496Ϯ28 mg/dL, Pϭ0.39; 1-tailed t test) and dyslipidemia (free fatty acids 2.1Ϯ0.05 versus 2.0Ϯ0.05 mmol/L, Pϭ0.11; cholesterol 1804Ϯ196 versus 1807Ϯ129 mg/dL, Pϭ0.49). By contrast, plasma 8-IsoP levels were lower in LDLR Figure 7B ; Pϭ0.017). Moreover, aortic pro-MMP9 activity was reduced in diabetic LDLR (Figure 7C and 7D; Pϭ0.04). Thus, OPN participates in isoprostane generation and aortic pro-MMP9 activation in the LDLR Ϫ/Ϫ mouse model of diet-induced diabetes. 4 
Oxylipids Preferentially Activate Pro-MMP9
Oxylipids not only reflect the presence of superoxide generation but also mediate inflammatory signals. 20 Thus, we tested the ability of oxylipid to activate pro-MMP9, evaluating 8-IsoP, which is among the many isoprostanes generated from the heterogeneous oxylipid precursor oxidized palmitoyl arachidonoyl phosphatidylcholine (Ox-PAPC). 19, 20 Like OPN and TNF-␣ ( Figure 1A Figure IIA) . We also tested the ability of 8-IsoP to activate pro-MMP9 in the presence of anti-OPN antibody in A7r5 cells, a treatment that reduces pro-MMP9 activity ( Figure 1D ; and Figure 8C , lanes 1 and 2) and endogenous 8-IsoP production ( Figure  3D ). As shown in Figure 8C , whereas anti-OPN decreased pro-MMP9 activity (lanes 1 and 2), 8-IsoP treatment dosedependently restored pro-MMP9 activity (lanes 3 to 5). In aqueous solutions, 3-morpholinosydnonimine-Nethylcarbamide (SIN-1) decomposes to form superoxide and nitric oxide (and thus peroxynitrite). 10 SIN-1 dosedependently upregulated 8-IsoP accumulation in A7r5 cells ( Figure 8D ), confirming that superoxide generates oxylipids in aortic VSMCs. Moreover, like OPN and 8-IsoP, SIN-1 upregulated pro-MMP9 but also enhanced MMP9 activation ( Figure 8E ). Little effect on MMP2 was noted. Thus, OPN- and superoxide-regulated oxylipids can participate in the activation of pro-MMP9 in VSMCs.
Discussion
VSMCs and AMFs participate in every aspect of arterial pathobiology. 23, 24 Proliferative and synthetic responses contribute to mural thickness, neointima formation, fibrosis, calcification, and vascular stiffening. 6 Contractile responses modulate arterial tone, wound repair, and hemostasis. 3, 23, 24 Very few well-validated markers differentiate VSMCs of the media from adventitial AMFs 24 ; however, AMFs exhibit higher levels of NADPH oxidase activity. 23, 24 Aortic AMFs elaborate robust metabolic responses in the setting of diabetes, dyslipidemia, and hypertension. 23, 24 Thus, both adventitial AMFs and mural VSMCs are important mediators of vascular disease progression. 3, 23, 24 SVVYGLR treatment activated oxidative stress in both adventitial and medial tissue compartments, consistent with our observations made with aortic AMF and VSMC culture models. Other vascular beds are also responsive, because Figure 6 . The OPN peptide SVVYGLR increases aortic pro-MMP9 activity, panmural oxidative stress, and isoprostane levels in vivo. OPN ϩ/Ϫ mice were treated with 2 intraperitoneal doses of either vehicle (nϭ5) or 8 g/gm SVVYGLR (nϭ5), and euthanized, and tissues were analyzed for pro-MMP9 by quantitative zymography (A, E, and F), oxidative stress by DHE staining (B and C), 8-IsoP levels (D), and NADPH oxidase subunits by Western blot (supplement Figure VA) . A, Aortic pro-MMP9 activity is significantly upregulated (1.5-fold; Pϭ0.03) in OPN ϩ/Ϫ mice treated with SVVYGLR peptide. B and C, DHE staining of frozen sections of thoracic aorta (B) or proximal ascending aorta (C) demonstrated increased oxidative stress in SVVYGLR-treated mice in both medial and adventitial compartments. D, Aortic tissue 8-IsoP levels were increased 2-fold (Pϭ0.019) in SVVYGLR-treated OPN ϩ/Ϫ mice. E and F, Pulmonary tissue significantly increased pro-MMP9 activity in response to SVVYGLR treatment. MMP2 activity was not affected.
pulmonary pro-MMP9 activity was significantly upregulated by OPN SVVYGLR peptide. Under basal conditions, total NADPH oxidase activity is higher in adventitial versus medial arterial compartments. 3, 23 With diabetes, adventitial oxidase activity is further enhanced, and tunica media NADPH oxidase is dramatically upregulated. 3 Because OPN is a hyperglycemia-induced cytokine, 5 the macrovascular oxidative stress of diabetes 3 is potentially augmented by paracrine OPN signaling. Consistent with this, both 8-IsoP levels and aortic pro-MMP9 activity are reduced in diabetic LDLR Ϫ/Ϫ mice lacking the OPN gene. Advanced glycosylation end products upregulate proinflammatory vascular cytokines such as TNF-␣. 3 Thus, in our working model (supplemental Figure IIA) , oxylipids 19 such as 8-IsoP generated via OPN-dependent signals would augment mural pro-MMP9 in diabetes. The plasma 8-IsoP levels observed in vivo ( Figure  7E ) are Ϸ1000-fold lower than those necessary to upregulate pro-MMP9 in vitro. Although 8-IsoP is 1 bioactive oxylipid generated in response to OPN signaling, many other oxylipids are produced during vascular disease progression. 19 Ox-PAPC, the oxylipid precursor of isoprostanes, 19,20 also activates pro-MMP9 (not shown). Thus, although 8-IsoP is 1 oxylipid readily assayed and studied, the spectrum of vascular oxylipids that are upregulated in diabetes and participate in pro-MMP9 activation has yet to be determined. Of note, oxylipids such as isoprostanes or 4-hydroxynonenal could activate pro-MMP9 via covalent alkylation reactions involving pro-MMP9 propeptide. 10 At high cell densities, we see no effect of BAY compound on OPN or TNF-␣ pro-MMP9 activation in vitro. However, when cells are sparsely subconfluent, BAY compound weakly inhibits MMP9 induction, suggesting that NF-B signaling contributes at low cell densities; moreover, unlike TNF-␣, pro-MMP9 activation by TGF-␤ is not altered by OPN deficiency (not shown). Thus, multiple pathways must participate in vascular MMP9 activation during development and disease.
Galis and Khatri first demonstrated that oxidative stress activates collagenases in phagocytes, including pro-MMP9 and MMP9 10 ; this resembles our results with SIN-1. Our data extend these observations by identifying that OPN signaling and oxylipids preferentially activate pro-MMP9 in aortic mesenchymal cells. 7 However, the specific NADPH oxidase complex mediating this vascular response is as yet unknown and may differ between media and adventitia. 18, 23 Future experiments will identify the relative contributions of NADPH oxidase isoforms to OPN signaling in medial versus adventitial tunics.
With diabetes, periaortic AMFs express high levels of OPN at the earliest stages of disease. 4 Both adventitial and medial oxidative stresses are enhanced in response to diabetesinduced NADPH oxidase activity. 3, 24 We propose that hyperglycemia-induced aortic OPN expression 4, 5 contributes to the vascular inflammation of diabetes, augmenting mural oxidative stress, pro-MMP9 activation, medial thickening, and matrix remodeling (supplemental Figure IIA) . Thus, strategies that inhibit paracrine OPN-superoxide signaling may ameliorate the macrovascular injury of diabetes. Liaw, Giachelli, and colleagues first showed that neutralizing OPN reduced neointima formation 25 ; whether this antibody concomitantly regulated vascular oxidative stress is currently unknown. Our data add to this evidence, 25 highlighting a potential benefit in selective inhibition of OPN SVVYGLR /OPN Ϫ/Ϫ mice were fed diabetogenic Western diets for 7 weeks, then analyzed as described in the online data supplement. No significant differences in fasting blood glucose, total cholesterol, or free fatty acids were observed. A, Plasma OPN levels are profoundly reduced in OPN Ϫ/Ϫ animals. Fasting plasma 8-IsoP levels (B) (Pϭ0.03) and aortic pro-MMP9 activation (C and D) (Pϭ0.04) were also significantly reduced in diabetic LDLR signaling as 1 strategy to reduce inflammatory vascular remodeling in diabetes and, thus, preserve macrovascular structure and function. 7, 25 
